{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:21:41Z","timestamp":1769721701691,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10072-021-05690-5","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T21:02:42Z","timestamp":1635368562000},"page":"2693-2698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intrathecal therapy for tuberculous meningitis: propensity-matched cohort study"],"prefix":"10.1007","volume":"43","author":[{"given":"Kunyi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3998-1400","authenticated-orcid":false,"given":"Maolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"5690_CR1","unstructured":"WHO. Global tuberculosis report 2019\u00a0. WHO. 2019"},{"key":"5690_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S1474-4422(19)30154-1","volume":"18","author":"J Donovan","year":"2019","unstructured":"Donovan J, Figaji A, Imran D et al (2019) The neurocritical care of tuberculous meningitis. Lancet Neurol 18:771\u2013783","journal-title":"Lancet Neurol"},{"key":"5690_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrneurol.2017.120","volume":"13","author":"RJ Wilkinson","year":"2017","unstructured":"Wilkinson RJ, Rohlwink U, Misra UK et al (2017) Tuberculous meningitis. Nat Rev Neurol 13:581\u2013598","journal-title":"Nat Rev Neurol"},{"key":"5690_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cmi.2015.09.023","volume":"22","author":"B Shofty","year":"2016","unstructured":"Shofty B, Neuberger A, Naffaa ME et al (2016) Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: matched cohort study. Clin Microbiol Infect 22:66\u201370","journal-title":"Clin Microbiol Infect"},{"key":"5690_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ijantimicag.2017.12.002","volume":"51","author":"S Chusri","year":"2018","unstructured":"Chusri S, Sakarunchai I, Kositpantawong N et al (2018) Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii. Int J Antimicrob Agents 51:646\u2013650","journal-title":"Int J Antimicrob Agents"},{"key":"5690_CR6","first-page":"551","volume":"5","author":"M Sofia","year":"2001","unstructured":"Sofia M, Maniscalco M, Honor\u00e9 N et al (2001) Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis. Int J Tuberc Lung Dis 5:551\u2013558","journal-title":"Int J Tuberc Lung Dis"},{"key":"5690_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2169\/internalmedicine.56.6945","volume":"56","author":"Y Nakatani","year":"2017","unstructured":"Nakatani Y, Suto Y, Fukuma K et al (2017) Intrathecal isoniazid for refractory tuberculous meningitis with cerebral infarction. Intern Med 56:953\u2013957","journal-title":"Intern Med"},{"key":"5690_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1086\/318698","volume":"32","author":"SE Berning","year":"2001","unstructured":"Berning SE, Cherry TA, Iseman MD (2001) Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis 32:643\u2013646","journal-title":"Clin Infect Dis"},{"key":"5690_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","volume":"10","author":"S Marais","year":"2010","unstructured":"Marais S, Thwaites G, Schoeman JF et al (2010) Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 10:803\u2013812","journal-title":"Lancet Infect Dis"},{"key":"5690_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/14787210.2017.1309974","volume":"15","author":"K Li","year":"2017","unstructured":"Li K, Tang H, Yang Y et al (2017) Clinical features, long-term clinical outcomes, and prognostic factors of tuberculous meningitis in West China: a multivariate analysis of 154 adults. Expert Rev Anti Infect Ther 15:629\u2013635","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5690_CR11","doi-asserted-by":"crossref","unstructured":"Streptomycin in Tuberculosis Trials Committee M R C. Streptomycin treatment of tuberculous meningitis. The Lancet. 1948,251:582\u2013596","DOI":"10.1016\/S0140-6736(48)92003-0"},{"key":"5690_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1136\/jnnp-2013-307178","volume":"85","author":"M Wasay","year":"2014","unstructured":"Wasay M, Farooq S, Khowaja ZA et al (2014) Cerebral infarction and tuberculoma in central nervous system tuberculosis: frequency and prognostic implications. J Neurol Neurosurg Psychiatry 85:1260\u20131264","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5690_CR13","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00415-019-09523-6","volume":"266","author":"L Wen","year":"2019","unstructured":"Wen L, Li M, Tao X, Xinyuan Y, Wang L, Li K (2019) Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis. Journal of Neurology 266:3009\u20133021","journal-title":"Journal of Neurology"},{"key":"5690_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC et al (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604\u2013607","journal-title":"Stroke"},{"key":"5690_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jinf.2009.06.011","volume":"59","author":"G Thwaites","year":"2009","unstructured":"Thwaites G, Fisher M, Hemingway C et al (2009) British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59:167\u2013187","journal-title":"J Infect"},{"key":"5690_CR16","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1080\/14656566.2019.1638912","volume":"20","author":"S Wasserman","year":"2019","unstructured":"Wasserman S, Davis A, Wilkinson RJ et al (2019) Key considerations in the pharmacotherapy of tuberculous meningitis. Expert Opin Pharmacother 20:1791\u20131795","journal-title":"Expert Opin Pharmacother"},{"key":"5690_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/17512433.2019.1552831","volume":"12","author":"FV Cresswell","year":"2019","unstructured":"Cresswell FV, Te Brake L, Atherton R et al (2019) Intensified antibiotic treatment of tuberculosis meningitis. Expert Rev Clin Pharmacol 12:267\u2013288","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5690_CR18","doi-asserted-by":"crossref","unstructured":"Ding J,Thuy Thuong Thuong N,Pham T V et al (2020) Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis.\u00a0Clin Pharmacol Ther 107:1023\u20131033","DOI":"10.1002\/cpt.1783"},{"key":"5690_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","volume":"281","author":"CM Nolan","year":"1999","unstructured":"Nolan CM, Goldberg SV, Buskin SE (1999) Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 281:1014\u20131018","journal-title":"JAMA"},{"key":"5690_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.apsb.2016.07.014","volume":"6","author":"P Wang","year":"2016","unstructured":"Wang P, Pradhan K, Zhong XB et al (2016) Isoniazid metabolism and hepatotoxicity. Acta Pharm Sin B 6:384\u2013392","journal-title":"Acta Pharm Sin B"},{"key":"5690_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1086\/513756","volume":"25","author":"B Pfausler","year":"1997","unstructured":"Pfausler B, Haring HP, Kampfl A et al (1997) Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage. Clin Infect Dis 25:733\u2013735","journal-title":"Clin Infect Dis"},{"key":"5690_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.clineuro.2018.05.007","volume":"170","author":"OD Mrowczynski","year":"2018","unstructured":"Mrowczynski OD, Langan ST, Rizk EB (2018) Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: a review and update. Clin Neurol Neurosurg 170:140\u2013158","journal-title":"Clin Neurol Neurosurg"},{"key":"5690_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/0284185116633913","volume":"58","author":"D Li","year":"2017","unstructured":"Li D, Lv P, Lv Y et al (2017) Magnetic resonance imaging characteristics and treatment aspects of ventricular tuberculosis in adult patients. Acta Radiol 58:91\u201397","journal-title":"Acta Radiol"},{"key":"5690_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WCO.0b013e32832c1396","volume":"22","author":"WC Ziai","year":"2009","unstructured":"Ziai WC, Lewin JJ (2009) 3rd Improving the role of intraventricular antimicrobial agents in the management of meningitis. Curr Opin Neurol 22:277\u2013282","journal-title":"Curr Opin Neurol"},{"key":"5690_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00381-012-1748-2","volume":"28","author":"J Lin","year":"2012","unstructured":"Lin J, Zhou H, Zhang N et al (2012) Effects of the implantation of Ommaya reservoir in children with tuberculous meningitis hydrocephalus: a preliminary study. Childs Nerv Syst 28:1003\u20131008","journal-title":"Childs Nerv Syst"},{"key":"5690_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/adc.31.158.328","volume":"31","author":"PN Swift","year":"1956","unstructured":"Swift PN (1956) Intrathecal isoniazid in tuberculous meningitis. Arch Dis Child 31:328\u2013332","journal-title":"Arch Dis Child"},{"key":"5690_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00228-012-1429-9","volume":"69","author":"J Azuma","year":"2013","unstructured":"Azuma J, Ohno M, Kubota R et al (2013) NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy. Eur J Clin Pharmacol 69:1091\u20131101","journal-title":"Eur J Clin Pharmacol"},{"key":"5690_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/17425255.2018.1416093","volume":"14","author":"I Motta","year":"2018","unstructured":"Motta I, Calcagno A, Bonora S (2018) Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?. Expert Opin Drug Metab Toxicol 14:59\u201382","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5690_CR29","doi-asserted-by":"crossref","unstructured":"Jing W, Zong Z, Tang B et al (2020) Population pharmacokinetic analysis of isoniazid among pulmonary tuberculosis patients from China. Antimicrob Agents Chemother 64:e01736\u201319","DOI":"10.1128\/AAC.01736-19"},{"key":"5690_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/cid\/ciz039","volume":"69","author":"KF Walsh","year":"2019","unstructured":"Walsh KF, Vilbrun SC, Souroutzidis A et al (2019) Improved outcomes with high-dose isoniazid in multidrug-resistant tuberculosis treatment in Haiti. Clin Infect Dis 69:717\u2013719","journal-title":"Clin Infect Dis"},{"key":"5690_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cid\/cir406","volume":"53","author":"KR Jacobson","year":"2011","unstructured":"Jacobson KR, Theron D, Victor TC et al (2011) Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. Clin Infect Dis 53:369\u2013372","journal-title":"Clin Infect Dis"},{"key":"5690_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","volume":"104","author":"DJ Begley","year":"2004","unstructured":"Begley DJ (2004) Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 104:29\u201345","journal-title":"Pharmacol Ther"},{"key":"5690_CR33","first-page":"378","volume":"78","author":"IC Danielides","year":"1983","unstructured":"Danielides IC, Constantoulakis M, Daikos GK (1983) Hepatitis on high dose isoniazid: reintroduction of the drug in severe tuberculous meningitis. Am J Gastroenterol 78:378\u2013380","journal-title":"Am J Gastroenterol"},{"key":"5690_CR34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0033-8389(22)00616-9","volume":"33","author":"DK Dastur","year":"1995","unstructured":"Dastur DK, Manghani DK, Udani PM (1995) Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am 33:733\u2013752","journal-title":"Radiol Clin North Am"},{"key":"5690_CR35","first-page":"Cd002244","volume":"4","author":"K Prasad","year":"2016","unstructured":"Prasad K, Singh MB, Ryan H (2016) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 4:Cd002244","journal-title":"Cochrane Database Syst Rev."},{"key":"5690_CR36","unstructured":"WHO. Treatment of tuberculosis guidelines. WHO. 2010, Fourth edition"},{"key":"5690_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S1474-4422(13)70168-6","volume":"12","author":"GE Thwaites","year":"2013","unstructured":"Thwaites GE, van Toorn R, Schoeman J (2013) Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 12:999\u20131010","journal-title":"Lancet Neurol"},{"key":"5690_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dadm.2017.04.007","volume":"8","author":"S Engelborghs","year":"2017","unstructured":"Engelborghs S, Niemantsverdriet E, Struyfs H et al (2017) Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst) 8:111\u2013126","journal-title":"Alzheimers Dement (Amst)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05690-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T23:51:06Z","timestamp":1673653866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05690-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5690"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05690-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"8 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed following local ethical standards and principles of Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Patients and members of the public were not involved in the study design, interpretation of results, or writing of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}